Medicure, Inc. (NASDAQ:MCUJF) | WebDisclosure

Basculer en Français

8300	Companies
115013	Keywords
55392	Articles
62492	Press releases

Home
Companies
Medicure, Inc.

PRESS RELEASE

published on 04/23/2024 at 23:00, 6 months 27 days ago

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Medicure Inc. receives FDA Fast Track designation for MC-1 to treat PNPO deficiency seizures, a serious condition. Rare Pediatric Disease and Orphan Drug designations granted

Medicure Inc. Orphan Drug Designation FDA Fast Track Designation MC-1 PNPO Deficiency Seizures
BRIEF

published on 04/08/2024 at 23:05, 7 months 12 days ago

Medicure Inc. réfléchit à son exercice 2023 et à ses performances au quatrième trimestre

Résultats Financiers Médicament Industrie Pharmaceutique AGGRASTAT ZYPITAMAG
BRIEF

published on 04/08/2024 at 23:05, 7 months 12 days ago

Medicure Inc. Reflects on its 2023 Financial Year and Q4 Performance

Financial Results Pharmaceutical Industry Medicure AGGRASTAT ZYPITAMAG
PRESS RELEASE

published on 04/08/2024 at 23:00, 7 months 12 days ago

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Medicure Inc. reports results from operations for the quarter and year ended December 31, 2023. Net revenue, EBITDA, and financial highlights disclosed

Financial Results EBITDA Quarterly Report Medicure Inc. Revenue Analysis
BRIEF

published on 04/05/2024 at 00:05, 7 months 16 days ago

Medicure Inc. to Announce 2023 Financial Results in Upcoming Conference Call

Financial Results Conference Call Pharmaceutical Industry Medicure Inc. 2023 Year End
BRIEF

published on 04/05/2024 at 00:05, 7 months 16 days ago

Medicure Inc. annoncera ses résultats financiers pour 2023 lors d'une prochaine conférence téléphonique

Résultats Financiers Medicure Inc. Conférence Téléphonique Fin D'année 2023 Industrie Pharmaceutique
PRESS RELEASE

published on 04/05/2024 at 00:00, 7 months 16 days ago

Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
Medicure Inc. to present 2023 Year End Financial Results on April 9, 2024, focusing on pharmaceuticals and healthcare products. Conference call details provided

Conference Call Pharmaceuticals Medicure Inc. Healthcare Products 2023 Year End Financial Results
PRESS RELEASE

published on 12/05/2023 at 23:00, 11 months 15 days ago

Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
Medicure Inc. announces a partnership with TheracosBio through Marley Drug to distribute BRENZAVVY, a new diabetes drug, at an affordable cash price, aiming to improve patient care in the US

Medicure Inc. TheracosBio BRENZAVVY Diabetes Drug Marley Drug
PRESS RELEASE

published on 11/23/2023 at 23:00, 11 months 27 days ago

Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
PRESS RELEASE

published on 11/21/2023 at 23:00, 11 months 29 days ago

Medicure Reports Financial Results for Quarter Ended September 30, 2023

Accesswire

Published on 11/21/2024 at 15:30, 11 minutes ago

CLS Health Opens New Comprehensive Care Clinic in Sugar Creek
Published on 11/21/2024 at 15:05, 36 minutes ago

"The Not-So-Secret Lives of REAL 'Mormon' Wives" - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/21/2024 at 15:00, 41 minutes ago

2-10 Home Buyers Warranty Makes Triumphant Entry Into Oklahoma Market
Published on 11/21/2024 at 15:00, 41 minutes ago

Sound Physicians’ ACO Achieves $22.9M Total Savings in 2023 Medicare Shared Savings Program
Published on 11/21/2024 at 15:00, 41 minutes ago

BlackBerry AtHoc "In Process" Finalization for FedRAMP High Authorization

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 15:24, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 18 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 19 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 15:20, 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Published on 11/21/2024 at 15:19, 22 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tritax EuroBox plc

Les Echos

Published on 11/21/2024 at 06:58, 8 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 8 hours 43 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 8 hours 43 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 19 hours 34 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 20 hours 21 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE